-
1
-
-
12444279265
-
On the origin of cancer cells
-
Warburg O. On the origin of cancer cells. Science. 1956;123(3191): 309-314
-
(1956)
Science
, vol.123
, Issue.3191
, pp. 309-314
-
-
Warburg, O.1
-
2
-
-
0033079597
-
Oncogenic alterations of metabolism
-
DOI 10.1016/S0968-0004(98)01344-9, PII S0968000498013449
-
Dang CV, Semenza GL. Oncogenic alterations of metabolism. Trends Biochem Sci. 1999;24(2):68-72 (Pubitemid 29346576)
-
(1999)
Trends in Biochemical Sciences
, vol.24
, Issue.2
, pp. 68-72
-
-
Dang, C.V.1
Semenza, G.L.2
-
3
-
-
0035021707
-
A tabulated summary of the FDG PET literature
-
Gambhir SS, Czernin J, Schwimmer J, et al. A tabulated summary of the FDG PET literature. J Nucl Med. 2001;42:(5 Suppl):1S-93S (Pubitemid 32423895)
-
(2001)
Journal of Nuclear Medicine
, vol.42
, Issue.5 SUPPL.
-
-
Gambhir, S.S.1
Czernin, J.2
Schwimmer, J.3
Silverman, D.H.S.4
Coleman, R.E.5
Phelps, M.E.6
-
4
-
-
84865976786
-
Anticancer targets in the glycolytic metabolism of tumors: A comprehensive review
-
doi:10.3389/fphar.2011.00049
-
Porporato PE, Dhup S, Dadhich RK, et al. Anticancer targets in the glycolytic metabolism of tumors: A comprehensive review. Front Pharmacol. 2011;2:49. doi:10.3389/fphar.2011.00049
-
(2011)
Front Pharmacol
, vol.2
, pp. 49
-
-
Porporato, P.E.1
Dhup, S.2
Dadhich, R.K.3
-
5
-
-
77954924659
-
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma
-
Stupp R, Hegi ME, Neyns B, et al. Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastoma. J ClinOncol. 2010;28(16):2712-2718
-
(2010)
J ClinOncol
, vol.28
, Issue.16
, pp. 2712-2718
-
-
Stupp, R.1
Hegi, M.E.2
Neyns, B.3
-
6
-
-
77951599543
-
Targeting brain cancer: Advances in the molecular pathology of malignant glioma and medulloblastoma
-
Huse JT, Holland EC. Targeting brain cancer: Advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer. 2010;10(5):319-331
-
(2010)
Nat Rev Cancer
, vol.10
, Issue.5
, pp. 319-331
-
-
Huse, J.T.1
Holland, E.C.2
-
7
-
-
80052714649
-
Molecular imaging of gliomas with PET: Opportunities and limitations
-
la Fougere C, Suchorska B, Bartenstein P, et al. Molecular imaging of gliomas with PET: Opportunities and limitations. Neuro Oncol. 2011; 13(8):806-819
-
(2011)
Neuro Oncol
, vol.13
, Issue.8
, pp. 806-819
-
-
La Fougere, C.1
Suchorska, B.2
Bartenstein, P.3
-
8
-
-
48949116219
-
Proton MR spectroscopy of cerebral gliomas at 3 T: Spatial heterogeneity, and tumour grade and extent
-
Di Costanzo A, Scarabino T, Trojsi F, et al. Proton MR spectroscopy of cerebral gliomas at 3 T: Spatial heterogeneity, and tumour grade and extent. Eur Radiol. 2008;18(8):1727-1735
-
(2008)
Eur Radiol
, vol.18
, Issue.8
, pp. 1727-1735
-
-
Di Costanzo, A.1
Scarabino, T.2
Trojsi, F.3
-
9
-
-
77952995998
-
Metabolicmodulation of glioblastoma with dichloroacetate
-
Michelakis ED, Sutendra G, Dromparis P, et al. Metabolicmodulation of glioblastoma with dichloroacetate. Sci Transl Med. 2010;2(31):31ra34
-
(2010)
Sci Transl Med
, vol.2
, Issue.31
, pp. 31-34
-
-
Michelakis, E.D.1
Sutendra, G.2
Dromparis, P.3
-
10
-
-
84875753357
-
Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized 13)C magnetic resonance spectroscopic imaging
-
Park JM, Recht LD, Josan S, et al. Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized (13)C magnetic resonance spectroscopic imaging. Neuro Oncol. 2013; 15(4):433-441
-
(2013)
Neuro Oncol
, vol.15
, Issue.4
, pp. 433-441
-
-
Park, J.M.1
Recht, L.D.2
Josan, S.3
-
11
-
-
2542561169
-
Akt stimulates aerobic glycolysis in cancer cells
-
DOI 10.1158/0008-5472.CAN-03-2904
-
Elstrom RL, Bauer DE, Buzzai M, et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004;64(11):3892-3899 (Pubitemid 38697301)
-
(2004)
Cancer Research
, vol.64
, Issue.11
, pp. 3892-3899
-
-
Elstrom, R.L.1
Bauer, D.E.2
Buzzai, M.3
Karnauskas, R.4
Harris, M.H.5
Plas, D.R.6
Zhuang, H.7
Cinalli, R.M.8
Alavi, A.9
Rudin, C.M.10
Thompson, C.B.11
-
12
-
-
84862016091
-
Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo
-
Marin-Valencia I, Yang C, Mashimo T, et al. Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab. 2012;15(6):827-837
-
(2012)
Cell Metab
, vol.15
, Issue.6
, pp. 827-837
-
-
Marin-Valencia, I.1
Yang, C.2
Mashimo, T.3
-
13
-
-
80053166769
-
Metabolic state of glioma stem cells and nontumorigenic cells
-
Vlashi E, Lagadec C, Vergnes L, et al. Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci U S A. 2011; 108(38):16062-16067
-
(2011)
Proc Natl Acad Sci U S A.
, vol.108
, Issue.38
, pp. 16062-16067
-
-
Vlashi, E.1
Lagadec, C.2
Vergnes, L.3
-
14
-
-
73649123907
-
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1
-
Verhaak RG, Hoadley KA, Purdom E, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98-110
-
(2010)
Cancer Cell
, vol.17
, Issue.1
, pp. 98-110
-
-
Verhaak, R.G.1
Hoadley, K.A.2
Purdom, E.3
-
15
-
-
26944452745
-
Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines
-
DOI 10.1007/s11060-004-6404-6
-
Griguer CE, Oliva CR, Gillespie GY. Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines. J Neurooncol. 2005;74(2):123-133 (Pubitemid 41478907)
-
(2005)
Journal of Neuro-Oncology
, vol.74
, Issue.2
, pp. 123-133
-
-
Griguer, C.E.1
Oliva, C.R.2
Gillespie, G.Y.3
-
16
-
-
80053452975
-
Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells
-
Sampetrean O, Saga I, Nakanishi M, et al. Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells. Neoplasia. 2011;13(9):784-791
-
(2011)
Neoplasia
, vol.13
, Issue.9
, pp. 784-791
-
-
Sampetrean, O.1
Saga, I.2
Nakanishi, M.3
-
17
-
-
84875767442
-
IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells
-
Osuka S, Sampetrean O, Shimizu T, et al. IGF1 receptor signaling regulates adaptive radioprotection in glioma stem cells. Stem Cells. 2013;31(4):627-640
-
(2013)
Stem Cells
, vol.31
, Issue.4
, pp. 627-640
-
-
Osuka, S.1
Sampetrean, O.2
Shimizu, T.3
-
18
-
-
77953888141
-
Quantitative metabolome profiling of Illicium anisatum by capillary electrophoresis time-of-flight mass spectrometry
-
Urakami K, Zangiacomi V, Yamaguchi K, et al. Quantitative metabolome profiling of Illicium anisatum by capillary electrophoresis time-of-flight mass spectrometry. Biomed Res. 2010;31(2):161-163
-
(2010)
Biomed Res
, vol.31
, Issue.2
, pp. 161-163
-
-
Urakami, K.1
Zangiacomi, V.2
Yamaguchi, K.3
-
19
-
-
37449024702
-
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
-
DeBerardinis RJ, LumJJ, Hatzivassiliou G, et al. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7(1):11-20
-
(2008)
Cell Metab
, vol.7
, Issue.1
, pp. 11-20
-
-
De Berardinis, R.J.1
Lum, J.J.2
Hatzivassiliou, G.3
-
20
-
-
80053916176
-
Metabolic regulation of hematopoietic stem cells in the hypoxic niche
-
Suda T, Takubo K, Semenza GL. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell. 2011;9(4):298-310
-
(2011)
Cell Stem Cell
, vol.9
, Issue.4
, pp. 298-310
-
-
Suda, T.1
Takubo, K.2
Semenza, G.L.3
-
21
-
-
84872011926
-
Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells
-
Takubo K, Nagamatsu G, Kobayashi CI, et al. Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell. 2013;12(1):49-61
-
(2013)
Cell Stem Cell
, vol.12
, Issue.1
, pp. 49-61
-
-
Takubo, K.1
Nagamatsu, G.2
Kobayashi, C.I.3
-
22
-
-
84868351585
-
Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal
-
Zhang J, Nuebel E, Daley GQ, et al. Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal. Cell Stem Cell. 2012;11(5):589-595
-
(2012)
Cell Stem Cell
, vol.11
, Issue.5
, pp. 589-595
-
-
Zhang, J.1
Nuebel, E.2
Daley, G.Q.3
-
23
-
-
42949149114
-
Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria
-
DOI 10.1038/sj.onc.1210949, PII 1210949
-
Gunther HS, Schmidt NO, Phillips HS, et al. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene. 2008;27(20): 2897-2909 (Pubitemid 351620450)
-
(2008)
Oncogene
, vol.27
, Issue.20
, pp. 2897-2909
-
-
Gunther, H.S.1
Schmidt, N.O.2
Phillips, H.S.3
Kemming, D.4
Kharbanda, S.5
Soriano, R.6
Modrusan, Z.7
Meissner, H.8
Westphal, M.9
Lamszus, K.10
-
24
-
-
35649014840
-
Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1
-
DOI 10.1128/MCB.00440-07
-
Kim JW, Gao P, Liu YC, et al. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol. 2007;27(21):7381-7393 (Pubitemid 350033646)
-
(2007)
Molecular and Cellular Biology
, vol.27
, Issue.21
, pp. 7381-7393
-
-
Kim, J.-W.1
Gao, P.2
Liu, Y.-C.3
Semenza, G.L.4
Dang, C.V.5
-
25
-
-
37549032776
-
The interplay between MYC and HIF in cancer
-
Dang CV, Kim JW, Gao P, et al. The interplay between MYC and HIF in cancer. Nat Rev Cancer. 2008;8(1):51-56
-
(2008)
Nat Rev Cancer
, vol.8
, Issue.1
, pp. 51-56
-
-
Dang, C.V.1
Kim, J.W.2
Gao, P.3
-
26
-
-
56849131763
-
C-Myc is required for maintenance of glioma cancer stem cells
-
Wang J, Wang H, Li Z, et al. c-Myc is required for maintenance of glioma cancer stem cells. PLoS One. 2008;3(11):e3769
-
(2008)
PLoS One
, vol.3
, Issue.11
-
-
Wang, J.1
Wang, H.2
Li, Z.3
-
27
-
-
0032915057
-
C-MYC oncogene family expression in glioblastoma and survival
-
DOI 10.1016/S0090-3019(98)00028-7, PII S0090301998000287
-
Herms JW, von Loewenich FD, Behnke J, et al. c-Myc oncogene family expression in glioblastoma and survival. Surg Neurol. 1999;51(5): 536-542 (Pubitemid 29218069)
-
(1999)
Surgical Neurology
, vol.51
, Issue.5
, pp. 536-542
-
-
Herms, J.W.1
Von Loewenich, F.D.2
Behnke, J.3
Markakis, E.4
Kretzschmar, H.A.5
|